Oncotelic Therapeutics Inc (OTLC)
0.038
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Oncotelic Therapeutics Total Liabilities (Quarterly): 18.72M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 18.72M |
December 31, 2023 | 18.40M |
September 30, 2023 | 18.01M |
June 30, 2023 | 18.09M |
March 31, 2023 | 17.60M |
December 31, 2022 | 16.92M |
September 30, 2022 | 16.21M |
June 30, 2022 | 16.11M |
March 31, 2022 | 16.81M |
December 31, 2021 | 15.45M |
September 30, 2021 | 14.80M |
June 30, 2021 | 14.13M |
March 31, 2021 | 13.03M |
December 31, 2020 | 11.18M |
September 30, 2020 | 8.764M |
June 30, 2020 | 8.216M |
March 31, 2020 | 8.484M |
December 31, 2019 | 6.783M |
September 30, 2019 | 2.728M |
June 30, 2019 | 2.043M |
March 31, 2019 | 1.174M |
December 31, 2018 | 1.161M |
September 30, 2018 | 1.091M |
June 30, 2018 | 1.561M |
March 31, 2018 | 1.524M |
Date | Value |
---|---|
December 31, 2017 | 1.649M |
September 30, 2017 | 1.211M |
June 30, 2017 | 1.425M |
March 31, 2017 | 1.393M |
December 31, 2016 | 1.614M |
September 30, 2016 | 1.485M |
June 30, 2016 | 1.617M |
March 31, 2016 | 2.024M |
December 31, 2015 | 2.103M |
September 30, 2015 | 1.698M |
June 30, 2015 | 1.166M |
March 31, 2015 | 1.029M |
December 31, 2014 | 1.419M |
September 30, 2014 | 1.674M |
June 30, 2014 | 1.948M |
March 31, 2014 | 1.395M |
December 31, 2013 | 1.251M |
September 30, 2013 | 1.515M |
June 30, 2013 | 0.891M |
March 31, 2013 | 0.833M |
December 31, 2012 | 0.901M |
September 30, 2012 | 1.251M |
June 30, 2012 | 1.618M |
March 31, 2012 | 1.475M |
December 31, 2011 | 2.259M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.043M
Minimum
Jun 2019
18.72M
Maximum
Mar 2024
13.12M
Average
15.13M
Median
Total Liabilities (Quarterly) Benchmarks
Mosaic ImmunoEngineering Inc | 6.051M |
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 29.97M |
Shareholders Equity (Quarterly) | 11.83M |